{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:36:24Z","timestamp":1715567784439},"reference-count":45,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,2,23]],"date-time":"2007-02-23T00:00:00Z","timestamp":1172188800000},"content-version":"vor","delay-in-days":905,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congestive Heart Failure"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p> <jats:italic>Aldosterone receptor antagonism (ARA) is an increasingly well\u2010accepted element of heart failure therapy. The experimental underpinnings for the use of ARA in heart failure are strong being linked to a variety of tissue\u2010based cardiac effects characteristic of drugs in this class. However, the benefits of ARA therapy do not come without some risk since drugs in this class are potent inhibitors of renal potassium (K+) elimination. Thus, some increment in serum K<jats:sup>+<\/jats:sup>, up to and including the development of overt hyperkalemia (typically defined as a serum K<jats:sup>+<\/jats:sup> value in excess of 6.0 mEq\/L), is to be expected whenever they are used. Hyperkalemia attributable to ARA relates to several factors including ARA dose, patient predisposition to hyperkalemia, as in the case of renal failure, and dietary intake of K<jats:sup>+<\/jats:sup>. The risk of some change in serum K<jats:sup>+<\/jats:sup> with ARA should not be a deterrent to use of drugs in this class but, rather should prompt careful surveillance for the onset of this potentially life\u2010threatening electrolyte disturbance. The frequency of such scrutiny should be patient\u2010specific and based on the constellation of risk factors for hyperkalemia.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1527-5299.2004.02814.x","type":"journal-article","created":{"date-parts":[[2007,2,24]],"date-time":"2007-02-24T04:20:09Z","timestamp":1172290809000},"page":"259-264","source":"Crossref","is-referenced-by-count":21,"title":["Aldosterone Receptor Antagonism: Interface With Hyperkalemia in Heart Failure"],"prefix":"10.1111","volume":"10","author":[{"given":"Domenic A.","family":"Sica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,23]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.137.7.842"},{"key":"e_1_2_11_3_2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diab.32.11.1028","article-title":"Impairment of insulin\u2010mediated glucose metabolism by hyperosmolarity in man","volume":"32","author":"Bratusch\u2010Marrain PR","year":"1983","journal-title":"Diabetes"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198002213020803"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80080-1"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1988.189"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02581-X"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01061372"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.1.26"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02580-8"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2003.10.012"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02694-3"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040135"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.11.1605"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90866-1"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199207020-00007"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90921-5"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000890"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7379.35"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6372.1189"},{"key":"e_1_2_11_24_2","unstructured":"Potassium Guidelines for Patients With Heart Failure. The Cleveland Clinic.Department of Patient Education and Health Information. Available at:http:www.clevelandclinic.orghealthhealth\u2010infodocs23002333.asp. AccessedAugust 13 2004."},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2004.03697.x"},{"key":"e_1_2_11_26_2","first-page":"67","article-title":"Renal failure related to angiotensin\u2010converting enzyme inhibitors","volume":"17","author":"Textor SC","year":"1997","journal-title":"Semin Nephrol"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90415-6"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90365-8"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00381.x"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1980.14"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199803000-00013"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90934-4"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(02)00434-1"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.881"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.145.6.1070"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(96)70012-4"},{"key":"e_1_2_11_37_2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.V281279","article-title":"Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine","volume":"2","author":"Kamel KS","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199610270-00025"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000022089"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1996.43869000.x"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022030-00006"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199200101-00004"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4101.096153"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-003-0043-8"},{"key":"e_1_2_11_45_2","first-page":"315","article-title":"Elderly heart failure patients with drug\u2010induced serious hyperkalemia","volume":"12","author":"Vanpee D","year":"2000","journal-title":"Aging"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00642-8"}],"container-title":["Congestive Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-5299.2004.02814.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-5299.2004.02814.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:42:20Z","timestamp":1697215340000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-5299.2004.02814.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1527-5299.2004.02814.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-5299.2004.02814.x","archive":["Portico"],"relation":{},"ISSN":["1527-5299","1751-7133"],"issn-type":[{"value":"1527-5299","type":"print"},{"value":"1751-7133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}